UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Oct 27, 2026
Sale
Calculated transaction value
$730.29K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Oct 26, 2026
Public filing date
Oct 27, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$592.84
Oct 26, 2026
First close after public filing
$586.48
Oct 28, 2026
Return after filing · so far
-4.17%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,241 shares @ $588.47
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000172
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$6.71M
Buys / sales
0 / 8
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Oct 26, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Oct 26, 2026 | $351.43K |
| United Therapeutics Corp UTHR | Sale | Oct 26, 2026 | $477.89K |
| United Therapeutics Corp UTHR | Sale | Oct 26, 2026 | $1.59M |
| United Therapeutics Corp UTHR Current | Sale | Oct 26, 2026 | $730.29K |
| United Therapeutics Corp UTHR | Sale | Oct 26, 2026 | $754.74K |
| United Therapeutics Corp UTHR | Sale | Oct 26, 2026 | $401.59K |
| United Therapeutics Corp UTHR | Sale | Oct 26, 2026 | $410.57K |
| United Therapeutics Corp UTHR | Exercise | Oct 26, 2026 | $0 |
| United Therapeutics Corp UTHR | Sale | Oct 26, 2026 | $875.12K |